Efficacy of Baricitinib in Patients with Refractory Adult-Onset Still's Disease
{{output}}
Background and objective: Adult-onset Still's disease (AOSD) is an idiopathic systemic inflammatory disease of unknown aetiology. Some patients exhibit resistance to conventional treatment during long-term therapy. Janus kinase i... ...
